Detailed company information
Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, an once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD); and Ampreloxetine an investigational, once-daily norepinephrine reuptake inhibitor, Which is in Phase 3 clinical trials for symptomatic neurogenic orthostatic hypotension (nOH) in patients with Multiple System Atrophy (MSA). It has a strategic collaboration agreement with Viatris Inc. for the development and commercialization of revefenacin, including YUPELRI inhalation solution. Theravance Biopharma, Inc. was incorporated in 2013 and is based in South San Francisco, California.
Last Updated: Sep 2026
Earnings Transcript for 2025 - Q3Released: Nov 10, 2025
Earnings Transcript for 2025 - Q2Released: Aug 12, 2025
Earnings Transcript for 2025 - Q1Released: May 08, 2025
Earnings Transcript for 2024 - Q4Released: Feb 26, 2025
Earnings Transcript for 2024 - Q3Released: Nov 12, 2024
Earnings Transcript for 2024 - Q2Released: Aug 05, 2024
Earnings Transcript for 2024 - Q1Released: May 13, 2024
Earnings Transcript for 2023 - Q4Released: Feb 26, 2024
Earnings Transcript for 2023 - Q3Released: Nov 07, 2023
Earnings Transcript for 2023 - Q2Released: Aug 07, 2023
Earnings Transcript for 2023 - Q1Released: May 08, 2023
Earnings Transcript for 2022 - Q4Released: Feb 27, 2023
Earnings Transcript for 2022 - Q3Released: Nov 07, 2022
Earnings Transcript for 2022 - Q2Released: Aug 07, 2022
Earnings Transcript for 2022 - Q1Released: May 07, 2022
Earnings Transcript for 2021 - Q4Released: Feb 23, 2022
Earnings Transcript for 2021 - Q3Released: Nov 03, 2021
Earnings Transcript for 2021 - Q2Released: Aug 03, 2021
Earnings Transcript for 2021 - Q1Released: May 04, 2021
Earnings Transcript for 2020 - Q4Released: Feb 23, 2021
Earnings Transcript for 2020 - Q3Released: Nov 08, 2020
Earnings Transcript for 2020 - Q2Released: Aug 08, 2020
Earnings Transcript for 2020 - Q1Released: May 06, 2020
Earnings Transcript for 2019 - Q4Released: Feb 24, 2020
Dafinchi
